Research ArticleArticle
The Proton Pump Inhibitor, Omeprazole, but Not Lansoprazole or Pantoprazole, Is a Metabolism-Dependent Inhibitor of CYP2C19: Implications for Coadministration with Clopidogrel
Brian W. Ogilvie, Phyllis Yerino, Faraz Kazmi, David B. Buckley, Amin Rostami-Hodjegan, Brandy L. Paris, Paul Toren and Andrew Parkinson
Drug Metabolism and Disposition November 2011, 39 (11) 2020-2033; DOI: https://doi.org/10.1124/dmd.111.041293
Brian W. Ogilvie
Phyllis Yerino
Faraz Kazmi
David B. Buckley
Amin Rostami-Hodjegan
Brandy L. Paris
Paul Toren
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
OMEPRAZOLE IS A METABOLISM-DEPENDENT INHIBITOR OF CYP2C19
Brian W. Ogilvie, Phyllis Yerino, Faraz Kazmi, David B. Buckley, Amin Rostami-Hodjegan, Brandy L. Paris, Paul Toren and Andrew Parkinson
Drug Metabolism and Disposition November 1, 2011, 39 (11) 2020-2033; DOI: https://doi.org/10.1124/dmd.111.041293
Research ArticleArticle
OMEPRAZOLE IS A METABOLISM-DEPENDENT INHIBITOR OF CYP2C19
Brian W. Ogilvie, Phyllis Yerino, Faraz Kazmi, David B. Buckley, Amin Rostami-Hodjegan, Brandy L. Paris, Paul Toren and Andrew Parkinson
Drug Metabolism and Disposition November 1, 2011, 39 (11) 2020-2033; DOI: https://doi.org/10.1124/dmd.111.041293
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement